- Home
- CERS vs GCO Comparison
CERS vs GCO Comparison
Compare CERS & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- GCO
- Stock Information
- Founded
- CERS 1991
- GCO 1924
- Country
- CERS United States
- GCO United States
- Employees
- CERS N/A
- GCO N/A
- Industry
- CERS EDP Services
- GCO Clothing/Shoe/Accessory Stores
- Sector
- CERS Technology
- GCO Consumer Discretionary
- Exchange
- CERS Nasdaq
- GCO Nasdaq
- Market Cap
- CERS 276.0M
- GCO 313.0M
- IPO Year
- CERS 1997
- GCO N/A
- Fundamental
- Price
- CERS $1.55
- GCO $27.65
- Analyst Decision
- CERS Strong Buy
- GCO Buy
- Analyst Count
- CERS 2
- GCO 3
- Target Price
- CERS $3.50
- GCO $32.67
- AVG Volume (30 Days)
- CERS 1.6M
- GCO 125.0K
- Earning Date
- CERS 10-29-2025
- GCO 08-28-2025
- Dividend Yield
- CERS N/A
- GCO N/A
- EPS Growth
- CERS N/A
- GCO N/A
- EPS
- CERS N/A
- GCO N/A
- Revenue
- CERS $192,510,000.00
- GCO $2,362,215,000.00
- Revenue This Year
- CERS $19.07
- GCO $4.60
- Revenue Next Year
- CERS $12.03
- GCO $2.14
- P/E Ratio
- CERS N/A
- GCO N/A
- Revenue Growth
- CERS 13.25
- GCO 2.66
- 52 Week Low
- CERS $1.12
- GCO $16.19
- 52 Week High
- CERS $2.24
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- CERS 54.85
- GCO 39.90
- Support Level
- CERS $1.52
- GCO $28.06
- Resistance Level
- CERS $1.70
- GCO $30.74
- Average True Range (ATR)
- CERS 0.10
- GCO 1.19
- MACD
- CERS -0.00
- GCO -0.53
- Stochastic Oscillator
- CERS 46.30
- GCO 22.39
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.